Importantly, we discovered that Btg2 is pathogenic in FSGS as conditional knockout of podocyte Btg2 protected against ADR‐induced FSGS by preventing podocyte injury such as the loss of podocyte markers, EMT, and the development of proteinuria and progressive glomerulosclerosis. This evidence concerns the gene BTG2 and focal segmental glomerulosclerosis.